Strata Critical Medical, Inc. (SRTA) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
SRTA EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SRTA Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 20.9% | -11.3% | 21.0% |
| 2024 | 23.7% | -13.6% | -11.0% |
| 2023 | 18.7% | -30.3% | -24.9% |
| 2022 | 15.2% | -36.6% | -18.7% |
| 2021 | 20.8% | -47.7% | -79.3% |
Download Data
Export SRTA earnings history in CSV or JSON format
Free sign-in required to download data
Strata Critical Medical, Inc. (SRTA) Earnings Overview
As of May 8, 2026, Strata Critical Medical, Inc. (SRTA) reported trailing twelve-month net income of $47M, reflecting +242.9% year-over-year growth. The company earned $0.52 per diluted share over the past four quarters, with a net profit margin of 21.0%.
Looking at the long-term picture, SRTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $41M in fiscal 2025, representing a new all-time high.
Strata Critical Medical, Inc. maintains industry-leading profitability with a gross margin of 20.9%, operating margin of -11.3%, and net margin of 21.0%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ENSG ($363M net income, 6.8% margin), ADUS ($100M net income, 6.7% margin), CCRN (-$99M net income, -9.0% margin), SRTA has outperformed on profitability metrics. Compare SRTA vs ENSG →
SRTA Earnings vs Peers
Earnings metrics vs comparable public companies
SRTA Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $41M | +251.4% | -$22M | $0.50 | 21.0% | -11.3% |
| 2024 | -$27M | +51.3% | -$34M | $-0.35 | -11.0% | -13.6% |
| 2023 | -$56M | -105.7% | -$68M | $-0.76 | -24.9% | -30.3% |
| 2022 | -$27M | +31.9% | -$54M | $-0.38 | -18.7% | -36.6% |
| 2021 | -$40M | -294.2% | -$24M | $-0.57 | -79.3% | -47.7% |
| 2020 | -$10M | +6.3% | -$10M | $-0.81 | -43.4% | -44.2% |
| 2019 | -$11M | - | -$12M | $-1.47 | -34.7% | -37.0% |
See SRTA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SRTA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SRTA vs SPIR
Side-by-side business, growth, and profitability comparison vs Spire Global, Inc..
Start ComparisonSRTA — Frequently Asked Questions
Quick answers to the most common questions about buying SRTA stock.
Is SRTA growing earnings?
SRTA EPS is $0.52, with earnings growth accelerating to +242.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $47M.
What are SRTA's profit margins?
Strata Critical Medical, Inc. net margin is +21.0%, with operating margin at -11.3%. Above-average margins indicate pricing power.
How consistent are SRTA's earnings?
SRTA earnings data spans 2019-2025. The accelerating earnings trend is +242.9% YoY. Historical data enables comparison across business cycles.